Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Water protons in bulk and tissue compartments refer to the hydrogen nuclei of water molecules found within the various physiological spaces of the body, including intracellular, interstitial, and intravascular environments. In the context of medical diagnostics, these protons are the fundamental source of signal in Magnetic Resonance Imaging (MRI), where their magnetic moments align with an external magnetic field (StatPearls: Magnetic Resonance Imaging Contrast Agents). While not a biological target for therapeutic intervention like a receptor or enzyme, they are the physical substrate for MRI contrast agents. These agents, typically paramagnetic complexes like gadolinium, catalyze the relaxation of water protons, thereby altering the signal intensity to highlight specific tissues or pathologies (NIH: Gadolinium-based contrast agents). The interaction occurs through dipole-dipole interactions between the unpaired electrons of the contrast agent and the water protons. Monitoring the behavior of these protons allows for the detection of structural and functional changes associated with diseases such as cancer, inflammation, and vascular disorders. Changes in water proton relaxation times are often used as biomarkers for tissue characterization and treatment response. Safety concerns in this field primarily relate to the toxicity of the contrast agents used to manipulate these protons, such as Nephrogenic Systemic Fibrosis (FDA: Gadolinium-based Contrast Agents).
Paramagnetic or superparamagnetic contrast agents interact with water protons via dipole-dipole interactions to shorten longitudinal (T1) and transverse (T2) relaxation times, thereby enhancing MRI signal intensity and contrast (StatPearls: Magnetic Resonance Imaging Contrast Agents).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Water protons in bulk and tissue compartments (1H).